Olmesartan Medoxomil
规格
144689-63-4CAS 号
604-433-1EC 号
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylateIUPAC 名称
C29H30N6O6化学式
558.6 g/mol分子量
Olmesartan medoxomil; 144689-63-4; Benicar; Olmetec; CS-866; Cs 866; DTXSID9045924; 6M97XTV3HD; NSC-758924; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; DTXCID7025924; TRIBENZOR COMPONENT OLMESARTAN MEDOXOMIL; CS866; Medoxomil, Olmesartan; RefChem:55771; 1H-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate; 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate-T287346; 604-433-1; C29H30N6O6; MFCD00944911; Olmesartan medoxomil (Standard); 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; NCGC00095136-01; Benevas; Olmesartan-d4Medoxomil; (5-Methyl-2-oxo-1,3-dioxol-4-yl)Methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-iMidazole-5-carboxylate; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate; Olsertain; Olvance; Benicar (TN); Olmetec (TN); SR-05000001987; UNII-6M97XTV3HD; votume; Openvas; CS-866DM; CS-866RN; Benicar;; Olmesartanmedoxomil; olmesartan-medoxomil; Olmesartan medoxomilo; Olmesartan medoxomil [USAN:INN:BAN]; KS-1182; Spectrum_001944; Olmesartan medoxomil CRS; Spectrum2_000506; Spectrum3_001676; Spectrum4_000740; Spectrum5_001556; SCHEMBL16403; SCHEMBL96150; BSPBio_003491; GTPL591; KBioGR_001040; KBioSS_002498; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester; MLS006010109; Olmetec; Benicar; CS 866; SPECTRUM1505205; SPBio_000431; Olmesartan medoxomil (Benicar); orb1226258; CHEMBL1200692; CHEBI:31932; KBio2_002490; KBio2_005058; KBio2_007626; KBio3_002711; HMS1922L15; HMS2089K18; HMS2093K16; HMS3651E13; HMS3715N09; HMS3743O09; HMS5079G18; Olmesartan medoxomil (JP17/USP); OLMESARTAN MEDOXOMIL [INN]; OLMESARTAN MEDOXOMIL [JAN]; Pharmakon1600-01505205; OLMESARTAN MEDOXOMIL [USAN]; OLMESARTAN MEDOXOMIL [VANDF]; Tox21_111445; BDBM50442892; CCG-39596; EBC-12821; HY-17005R; MSK158406; NSC758924; OLMESARTAN MEDOXOMIL [MART.]; OLMESARTAN MEDOXOMIL [USP-RS]; OLMESARTAN MEDOXOMIL [WHO-DD]; AKOS015894907; AKOS015914772; AC-1601; CCG-221184; CS-0577; IH57934; NSC 758924; Olmesartan medoxomil, >=98% (HPLC); SB19327; NCGC00095136-02; NCGC00095136-03; NCGC00095136-09; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate; (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate; AZOR COMPONENT OLMESARTAN MEDOXOMIL; HY-17005; OLMESARTAN MEDOXOMIL [ORANGE BOOK]; SMR002203616; OLMESARTAN MEDOXOMIL [EP MONOGRAPH]; SBI-0206741.P001; OLMESARTAN MEDOXOMIL [USP MONOGRAPH]; CAS-144689-63-4; CS-0694888; NS00008255; O0510; O4549; SW199650-2; D01204; EN300-122375; Olmesartan medoxomil for system suitability CRS; AB01275443-01; AB01275443_02; AB01275443_03; BENICAR HCT COMPONENT OLMESARTAN MEDOXOMIL; L001061; SR-05000001987-1; SR-05000001987-2; BRD-K78485176-001-02-9; BRD-K78485176-001-03-7; BRD-K78485176-001-06-0; BRD-K78485176-001-07-8; Q27888058; Z1541759904; Olmesartan Medoxomil Working Standard (Secondary Reference Standard); Olmesartan medoxomil, European Pharmacopoeia (EP) Reference Standard; Olmesartan medoxomil, United States Pharmacopeia (USP) Reference Standard; Olmesartan medoxomil for system suitability, European Pharmacopoeia (EP) Reference Standard; Olmesartan Medoxomil, Pharmaceutical Secondary Standard; Certified Reference Material; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-4-(2-hydroxypr; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylate; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate; (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole-5-carboxylate; (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate; (5-Methyl-2-oxo-1,3-dioxolen-4yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate; (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate; 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, (5-METHYL-2-OXO-1,3- DIOXOL-4-YL)METHYL ESTER; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imi; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; 5-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-IMIDAZOLE-4-CARBOXYLIC ACID 5-METHYL-2-OXO-[1,3]DIOXOL-4-YLMETHYL ESTER同义词
含有Olmesartan Medoxomil的产品
올메비카에이치씨티정2.5/20/12.5밀리그램(에스암로디핀베실산염이수화물,올메사르탄메독소밀,히드로클로로티아지드)올메비카에이치씨티정2.5/40/12.5밀리그램(에스암로디핀베실산염이수화물,올메사르탄메독소밀,히드로클로로티아지드)올메비카에이치씨티정5/40/12.5밀리그램(에스암로디핀베실산염이수화물,올메사르탄메독소밀,히드로클로로티아지드)이텍스올메사탄정10밀리그램(올메사르탄메독소밀)올바스타정20/10밀리그램올바스타정20/5밀리그램올프로정20/20밀리그램올로듀엣정20/20밀리그램올로듀엣정20/5밀리그램올로듀엣정20/10밀리그램올프로정20/10밀리그램올프로정20/5밀리그램
第 1/70 页
销售Olmesartan Medoxomil的公司
(주
(주)동구바이오제약Republic of Korea(주
(주)휴온스Republic of Korea第 1/16 页